Cargando…

Radiotherapy for glioblastoma patients with poor performance status

PURPOSE: There is limited information on treatment recommendations for glioblastoma patients with poor performance status. Here, we aim to evaluate the association of radiotherapy on survival in glioblastoma patients presenting with poor postoperative performance status in first-line setting. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schröder, Christina, Gramatzki, Dorothee, Vu, Erwin, Guckenberger, Matthias, Andratschke, Nicolaus, Weller, Michael, Hertler, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article – Clinical Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293860/ https://www.ncbi.nlm.nih.gov/pubmed/34448057 http://dx.doi.org/10.1007/s00432-021-03770-9

Ejemplares similares

Radiomic Analysis to Predict Outcome in Recurrent Glioblastoma Based on Multi-Center MR Imaging From the Prospective DIRECTOR Trial
por: Vils, Alex, et al.
Publicado: (2021)

Single-institution analysis of the prevalence, indications and outcomes of end-of-life radiotherapy
por: Christ, Sebastian M., et al.
Publicado: (2021)

Stereotactic Body Radiation Therapy (SBRT) as Salvage Therapy for Oligorecurrent Pleural Mesothelioma After Multi-Modality Therapy
por: Schröder, Christina, et al.
Publicado: (2019)

Validation and extension of the METSSS score in a metastatic cancer patient cohort after palliative radiotherapy within the last phase of life
por: Christ, Sebastian M., et al.
Publicado: (2022)

Repeated Courses of Radiosurgery for New Brain Metastases to Defer Whole Brain Radiotherapy: Feasibility and Outcome With Validation of the New Prognostic Metric Brain Metastasis Velocity
por: Fritz, Corinna, et al.
Publicado: (2018)

Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?
por: Rühle, Alexander, et al.
Publicado: (2019)

Venous thromboembolic events in glioblastoma patients: An epidemiological study
por: Eisele, Amanda, et al.
Publicado: (2022)

Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results?
por: Nieder, Carsten, et al.
Publicado: (2023)

Re-irradiation of recurrent IDH-wildtype glioblastoma in the bevacizumab and immunotherapy era: Target delineation, outcomes and patterns of recurrence
por: Christ, Sebastian M., et al.
Publicado: (2023)

MLTI-09. UNDERWEIGHT AND WEIGHT LOSS ARE PREDICTORS OF POOR OUTCOME IN PATIENTS WITH BRAIN METASTASIS
por: Weller, Michael, et al.
Publicado: (2019)

Sex-specific and gender-specific aspects in patient-reported outcomes
por: Hertler, Caroline, et al.
Publicado: (2020)

Associations of levetiracetam use with the safety and tolerability profile of chemoradiotherapy for patients with newly diagnosed glioblastoma
por: Seystahl, Katharina, et al.
Publicado: (2022)

Stereotactic body radiotherapy to defer systemic therapy in patients with oligorecurrent disease
por: Willmann, Jonas, et al.
Publicado: (2022)

Editorial: Precision medicine approaches in radiotherapy and systemic therapy of brain metastases
por: Kaul, David, et al.
Publicado: (2023)

Management of multiple brain metastases: a patterns of care survey within the German Society for Radiation Oncology
por: Kraft, Johannes, et al.
Publicado: (2021)

Robustness of radiomic features in magnetic resonance imaging for patients with glioblastoma: Multi-center study
por: Saltybaeva, Natalia, et al.
Publicado: (2022)

A tumor-promoting role for soluble TβRIII in glioblastoma
por: Burghardt, Isabel, et al.
Publicado: (2021)

Mortality during or shortly after curative-intent radio-(chemo-) therapy over the last decade at a large comprehensive cancer center
por: Christ, Sebastian M., et al.
Publicado: (2023)

Combined Radio- and Chemotherapy for Non-Small Cell Lung Cancer: Systematic Review of Landmark Studies Based on Acquired Citations
por: Nieder, Carsten, et al.
Publicado: (2013)

Corrigendum to “Robustness of radiomic features in magnetic resonance imaging for patients with glioblastoma: Multi-center study” [Phys. Imaging Radiat. Oncol. 22 (2022) 131–136]
por: Saltybaeva, Natalia, et al.
Publicado: (2022)

Personalized treatment of brain metastases: Evolving survival prediction models may benefit from evaluation of serum tumor markers (narrative review)
por: Nieder, Carsten, et al.
Publicado: (2022)

How we treat octogenarians with brain metastases
por: Nieder, Carsten, et al.
Publicado: (2023)

Endoglin and TGF-β signaling in glioblastoma
por: Burghardt, Isabel, et al.
Publicado: (2021)

Synthetic computed tomography for low-field magnetic resonance-guided radiotherapy in the abdomen
por: Lapaeva, Mariia, et al.
Publicado: (2022)

Transforming growth factor-β pathway activity in glioblastoma
por: Frei, Karl, et al.
Publicado: (2015)

Head and neck radiotherapy on the MR linac: a multicenter planning challenge amongst MRIdian platform users
por: Chamberlain, Madalyne, et al.
Publicado: (2021)

Hypofractionated Radiotherapy and Stereotactic Boost with Concurrent and Adjuvant Temozolamide for Glioblastoma in Good Performance Status Elderly Patients – Early Results of a Phase II Trial
por: Floyd, Scott R., et al.
Publicado: (2012)

Patient-specific quality assurance strategies for synthetic computed tomography in magnetic resonance-only radiotherapy of the abdomen
por: Dal Bello, Riccardo, et al.
Publicado: (2023)

Association of perioperative adverse events with subsequent therapy and overall survival in patients with WHO grade III and IV gliomas
por: Weber, Lorenz, et al.
Publicado: (2022)

In-field stereotactic body radiotherapy (SBRT) reirradiation for pulmonary malignancies as a multicentre analysis of the German Society of Radiation Oncology (DEGRO)
por: John, Caroline, et al.
Publicado: (2021)

Predicting Adverse Radiation Effects in Brain Tumors After Stereotactic Radiotherapy With Deep Learning and Handcrafted Radiomics
por: Keek, Simon A., et al.
Publicado: (2022)

Intra- and inter-fraction breath-hold variations and margins for radiotherapy of abdominal targets
por: Ehrbar, Stefanie, et al.
Publicado: (2023)

Stereotactic Body Radiotherapy as Primary Therapy for Head and Neck Cancer in the Elderly or Patients with Poor Performance
por: Amini, Arya, et al.
Publicado: (2014)

MLK3 Is Associated With Poor Prognosis in Patients With Glioblastomas and Actin Cytoskeleton Remodeling in Glioblastoma Cells
por: Zhu, Yan, et al.
Publicado: (2021)

Dosimetric Comparison of Upfront Boosting With Stereotactic Radiosurgery Versus Intraoperative Radiotherapy for Glioblastoma
por: Sarria, Gustavo R., et al.
Publicado: (2021)

Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib
por: Lewitzki, Victor, et al.
Publicado: (2015)

Synthetic computed tomography for low-field magnetic resonance-only radiotherapy in head-and-neck cancer using residual vision transformers
por: La Greca Saint-Esteven, Agustina, et al.
Publicado: (2023)

Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial
por: Krayenbuehl, J., et al.
Publicado: (2017)

Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer
por: Wujanto, Caryn, et al.
Publicado: (2019)

Correction to: Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial
por: Krayenbuehl, J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m7mjia002h358qk1uoeqdl6hue